Expansion Adds to Growing Global Trial FootprintPatient Screening and Enrollment Expected to Begin in Q2 2026SOUTH SAN FRANCISCO, Calif., April ...

A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) ...

By enrolling the world's first participant, the Sarah Cannon Transplant & Cellular Therapy Program at St. David's South Austin Medical Center made this therapy available to patients before it was ...

Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from ...

The investment bank made the move after Climb announced it had received FDA Fast Track Designation for its lead drug ...

Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...

Researchers at the Josep Carreras Leukaemia Research Institute (IJC) discover that a single molecular switch, HDAC7, controls ...

Deep in the lungs, resident memory B cells stand guard against influenza reinfection—but whether they remain there may depend ...